CS logo
small CS logo
Prisma Health Cancer Institute - Greer

Greer, South Carolina, United States
Cancer treatment center in Greer, South Carolina
340 Medical Pkwy, Greer, SC 29650

About Prisma Health Cancer Institute - Greer


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
100
Alliance for Clinical Trials in Oncology
52
SWOG Cancer Research Network
51
NRG Oncology
17
ECOG-ACRIN Cancer Research Group
16
Wake Forest University Health Sciences
9
Gynecologic Oncology Group
6
Radiation Therapy Oncology Group
5
Children's Oncology Group
3
GOG Foundation
3
NSABP Foundation Inc
3
Total Rows: 17

Clinical Trials at Prisma Health Cancer Institute - Greer


During the past decade, Prisma Health Cancer Institute - Greer conducted 142 clinical trials. In the 10-year time frame, 142 clinical trials started and 115 clinical trials were completed, i.e. on average, 81% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 62 clinical trials were completed. i.e. 238.5% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years18181818272722223131131399444477191910101313181819191414Started TrialsCompleted Trails20152016201720182019202020212022010203040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
1999-04-01
Active, not recruiting
840
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
1984-06-01
Active, not recruiting
9,000
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
2003-11-01
2027-01-01
Active, not recruiting
3,294
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
2006-03-01
2015-08-01
Completed
97
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
2006-04-24
2021-09-01
Completed
1,943
S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo
2006-10-01
2017-07-11
Completed
624

Rows per page:

1–100 of 274

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Prisma Health Cancer Institute - Greer" #1 sponsor was "National Cancer Institute (NCI)" with 100 trials, followed by "Alliance for Clinical Trials in Oncology" with 52 trials sponsored, "SWOG Cancer Research Network" with 51 trials sponsored, "NRG Oncology" with 17 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Prisma Health Cancer Institute - Greer" #1 collaborator was "National Cancer Institute (NCI)" with 167 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 48 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 100National CancerInstitute (NCI): 100Alliance for ClinicalTrials in Oncology: 52Alliance for ClinicalTrials in Oncology: 52SWOG Cancer ResearchNetwork: 51SWOG Cancer ResearchNetwork: 51NRG Oncology: 17NRG Oncology: 17ECOG-ACRIN CancerResearch Group: 16ECOG-ACRIN CancerResearch Group: 16Wake Forest UniversityHealth Sciences: 9Wake Forest UniversityHealth Sciences: 9Gynecologic Oncology Group: 6Gynecologic Oncology Group: 6Radiation TherapyOncology Group: 5Radiation TherapyOncology Group: 5Children's Oncology Group: 3Children's Oncology Group: 3GOG Foundation: 3GOG Foundation: 3

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 167National CancerInstitute (NCI): 167NRG Oncology: 26NRG Oncology: 26Canadian Cancer TrialsGroup: 12Canadian Cancer TrialsGroup: 12Cancer and LeukemiaGroup B: 5Cancer and LeukemiaGroup B: 5NCIC Clinical Trials Group: 5NCIC Clinical Trials Group: 5SWOG Cancer ResearchNetwork: 4SWOG Cancer ResearchNetwork: 4Eastern CooperativeOncology Group: 3Eastern CooperativeOncology Group: 3Radiation TherapyOncology Group: 3Radiation TherapyOncology Group: 3Alliance for ClinicalTrials in Oncology: 2Alliance for ClinicalTrials in Oncology: 2Astellas Pharma US, Inc.: 2Astellas Pharma US, Inc.: 2

Clinical Trials Conditions at Prisma Health Cancer Institute - Greer


According to Clinical.Site data, the most researched conditions in "Prisma Health Cancer Institute - Greer" are "Breast Cancer" (17 trials), "Colorectal Cancer" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Invasive Breast Carcinoma" (7 trials) and "Stage II Breast Cancer" (7 trials). Many other conditions were trialed in "Prisma Health Cancer Institute - Greer" in a lesser frequency.

Clinical Trials Intervention Types at Prisma Health Cancer Institute - Greer


Most popular intervention types in "Prisma Health Cancer Institute - Greer" are "Drug" (206 trials), "Other" (178 trials), "Biological" (88 trials), "Procedure" (57 trials) and "Radiation" (54 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (73 trials), "Quality-of-Life Assessment" (69 trials), "Questionnaire Administration" (48 trials), "Cisplatin" (31 trials) and "Carboplatin" (25 trials). Other intervention names were less common.

Clinical Trials Genders at Prisma Health Cancer Institute - Greer


The vast majority of trials in "Prisma Health Cancer Institute - Greer" are 215 trials for "All" genders, 44 trials for "Female" genders and 15 trials for "Male" genders.

Clinical Trials Status at Prisma Health Cancer Institute - Greer


Currently, there are NaN active trials in "Prisma Health Cancer Institute - Greer". undefined are not yet recruiting, 61 are recruiting, 127 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Prisma Health Cancer Institute - Greer, 6 suspended trials, and 15 terminated clinical trials to date.
Out of the total trials that were conducted in Prisma Health Cancer Institute - Greer, 6 "Phase 1" clinical trials were conducted, 111 "Phase 2" clinical trials and 142 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 17 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 142Phase 3: 142Phase 2: 111Phase 2: 111Not Applicable: 17Not Applicable: 17Phase 1: 6Phase 1: 6Early Phase 1: 2Early Phase 1: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 127Active, not recruiting: 127Completed: 63Completed: 63Recruiting: 61Recruiting: 61Terminated: 15Terminated: 15Suspended: 6Suspended: 6Unknown status: 2Unknown status: 2